114 related articles for article (PubMed ID: 20059967)
21. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
22. KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes.
Bellone G; Smirne C; Carbone A; Buffolino A; Scirelli T; Prati A; Solerio D; Pirisi M; Valente G; Nano M; Emanuelli G
Int J Oncol; 2006 Oct; 29(4):851-9. PubMed ID: 16964380
[TBL] [Abstract][Full Text] [Related]
23. Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors.
Melhem MF; Meisler AI; Finley GG; Bryce WH; Jones MO; Tribby II; Pipas JM; Koski RA
Cancer Res; 1992 Nov; 52(21):5853-64. PubMed ID: 1394214
[TBL] [Abstract][Full Text] [Related]
24. Clinical implications of fibroblast activation protein in patients with colon cancer.
Henry LR; Lee HO; Lee JS; Klein-Szanto A; Watts P; Ross EA; Chen WT; Cheng JD
Clin Cancer Res; 2007 Mar; 13(6):1736-41. PubMed ID: 17363526
[TBL] [Abstract][Full Text] [Related]
25. Myb expression is higher in malignant human colonic carcinoma and premalignant adenomatous polyps than in normal mucosa.
Ramsay RG; Thompson MA; Hayman JA; Reid G; Gonda TJ; Whitehead RH
Cell Growth Differ; 1992 Oct; 3(10):723-30. PubMed ID: 1445802
[TBL] [Abstract][Full Text] [Related]
26. Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa.
Gianani R; Jarboe E; Orlicky D; Frost M; Bobak J; Lehner R; Shroyer KR
Hum Pathol; 2001 Jan; 32(1):119-25. PubMed ID: 11172305
[TBL] [Abstract][Full Text] [Related]
27. Expression of Sonic hedgehog pathway genes is altered in colonic neoplasia.
Oniscu A; James RM; Morris RG; Bader S; Malcomson RD; Harrison DJ
J Pathol; 2004 Aug; 203(4):909-17. PubMed ID: 15258993
[TBL] [Abstract][Full Text] [Related]
28. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of beta3-adrenergic receptor mRNA in human colon cancer: a preliminary study.
Perrone MG; Notarnicola M; Caruso MG; Tutino V; Scilimati A
Oncology; 2008; 75(3-4):224-9. PubMed ID: 18852493
[TBL] [Abstract][Full Text] [Related]
30. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates.
Yang GY; Shamsuddin AM
Anticancer Res; 1995; 15(6B):2479-87. PubMed ID: 8669811
[TBL] [Abstract][Full Text] [Related]
31. DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation.
Wang L; Cao XX; Chen Q; Zhu TF; Zhu HG; Zheng L
Cancer Sci; 2009 Oct; 100(10):1801-8. PubMed ID: 19572978
[TBL] [Abstract][Full Text] [Related]
32. Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status.
Al-Ayyoubi S; Gali-Muhtasib H
Mol Carcinog; 2007 Mar; 46(3):176-86. PubMed ID: 17192871
[TBL] [Abstract][Full Text] [Related]
33. Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment.
Arlt MJ; Novak-Hofer I; Gast D; Gschwend V; Moldenhauer G; Grünberg J; Honer M; Schubiger PA; Altevogt P; Krüger A
Cancer Res; 2006 Jan; 66(2):936-43. PubMed ID: 16424028
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions.
Guo YS; Jin GF; Townsend CM; Zhang T; Sheng HM; Beauchamp RD; Thompson JC
J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387
[TBL] [Abstract][Full Text] [Related]
35. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.
Vécsey-Semjén B; Becker KF; Sinski A; Blennow E; Vietor I; Zatloukal K; Beug H; Wagner E; Huber LA
Oncogene; 2002 Jul; 21(30):4646-62. PubMed ID: 12096341
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model.
Melstrom LG; Bentrem DJ; Salabat MR; Kennedy TJ; Ding XZ; Strouch M; Rao SM; Witt RC; Ternent CA; Talamonti MS; Bell RH; Adrian TA
Clin Cancer Res; 2008 Oct; 14(20):6525-30. PubMed ID: 18927292
[TBL] [Abstract][Full Text] [Related]
37. Expression of epidermal growth factor receptor in normal colonic mucosa and in adenocarcinomas of the colon.
Ozğul C; Karaöz E; Erdoğan D; Dursun A
Acta Physiol Hung; 1997-1998; 85(2):121-8. PubMed ID: 9706306
[TBL] [Abstract][Full Text] [Related]
38. Expression of human apolipoprotein(a) kringles in colon cancer cells suppresses angiogenesis-dependent tumor growth and peritoneal dissemination.
Yu HK; Ahn JH; Lee HJ; Lee SK; Hong SW; Yoon Y; Kim JS
J Gene Med; 2005 Jan; 7(1):39-49. PubMed ID: 15517541
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical expression of mutant p53 oncogene in transitional mucosa adjacent to human colon cancer.
Baytner S; Mitmaker B; Gordon PH; Wang E
Clin Invest Med; 1993 Oct; 16(5):379-85. PubMed ID: 8261691
[TBL] [Abstract][Full Text] [Related]
40. Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines.
Sakamoto J; Furukawa K; Cordon-Cardo C; Yin BW; Rettig WJ; Oettgen HF; Old LJ; Lloyd KO
Cancer Res; 1986 Mar; 46(3):1553-61. PubMed ID: 3510728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
